Market revenue in 2023 | USD 50.6 million |
Market revenue in 2030 | USD 83.8 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Software |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Instruments was the largest segment with a revenue share of 34.78% in 2023. Horizon Databook has segmented the Mexico flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is the third-largest pharmaceutical market in Latin America. Mexico has emerged as one of the potential countries for biopharmaceutical products owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework. Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector.
In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector. Thus, growing biopharmaceutical and biotechnology industries in the country are anticipated to create high demand for flow cytometry products in the region and support market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account